Title: Promising Results: First Patient in Phase 1 Clinical Trial of PMB-CT01 Achieves Complete Remission for Relapsed and Refractory B-cell...
New EU Approval Granted to Roche’s Cancer Immunotherapy Roche, a leading pharmaceutical company, has recently received approval from the European...
Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow. It is characterized by...
Fungal infections may not always be at the forefront of public health concerns, but they pose a significant global threat,...
A Comprehensive Guide to Modern Oncologic Treatment Cartography: Chess Strategies Against Cancer Introduction: Cancer is a complex and multifaceted disease...
The US Health Agency Acknowledges the Medical Benefits of Cannabis, Marking a Historic Milestone In a groundbreaking move, the United...
Predicting Heart Risk in Asymptomatic Childhood Cancer through Two Common Biomarkers Childhood cancer survivors often face long-term health complications due...
Stem cell research has been a topic of great interest and controversy in the scientific community for many years. Stem...
Open Enrollment Begins for Phase 1b/2 Study Assessing Ampligen and Imfinzi Combination for Pancreatic Cancer Treatment Pancreatic cancer is one...
Merck Initiates Crucial Phase III Trials for New Drugs Targeting Oncologic and Hematologic Malignancies Merck, a leading pharmaceutical company, has...
Allogene Therapeutics, a leading biotechnology company specializing in the development of innovative cell therapies for cancer treatment, has recently announced...
Everything You Need to Know About Marijuana: Your Questions Answered Marijuana, also known as cannabis, has been a topic of...
How Revolutionary Nanodrones Facilitate Precise Cancer Treatment Cancer treatment has come a long way in recent years, with advancements in...
The Asian Fund for Cancer Research (AFCR) has recently announced Degron Therapeutics as the recipient of its prestigious 2023 award....
Lapatinib Demonstrates Improved Overall Survival in Metastatic Breast Cancer Patients with HER2-Positive Circulating Tumor Cells, According to Drugs.com MedNews
Lapatinib, a targeted therapy drug, has shown promising results in improving overall survival rates in metastatic breast cancer patients with...